Does Fidaxomicin reduce Cure and Recurrence rates compared to Vancomycin in Clostridium Difficile Infection patients?: A Systematic Review and Meta-analysis. GAIMS J MED SCI [Internet]. 2022 Jun. 12 [cited 2025 Oct. 31];2(1 (Jan-Jun):30-5. Available from: https://gjms.gaims.ac.in/index.php/gjms/article/view/43